Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3400 participants
OBSERVATIONAL
2022-05-14
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This will be accomplished by conducting a population-based prospective cohort study. A sample of individuals who live within the study base, i.e., the county containing each PLUS clinical research center and each adjacent county, will be invited to complete two baseline surveys and then two follow-up surveys one year later. A subset of participants will be invited to attend an in-person evaluation to collect additional clinical information and biologic specimens.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of Bladder Health Instrument for Evaluation in Women
NCT04016298
Evaluating UTI Outcomes in at Risk Populations
NCT05385536
Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms
NCT05276466
Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections
NCT03819712
Urinalysis Results in Healthy Individuals
NCT04055675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
* Identify or born as female (includes cis- and trans-women, and trans-men)
* Able to read and understand English or Spanish
* Able to read and provide informed consent
Exclusion Criteria
* Residence in a nursing home or other institutionalized living facility.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Diego
OTHER
University of Pennsylvania
OTHER
Yale University
OTHER
University of Michigan
OTHER
Loyola University Chicago
OTHER
University of Alabama at Birmingham
OTHER
Washington University School of Medicine
OTHER
Northwestern University
OTHER
Emory University
OTHER
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Siobhan Sutcliffe, PhD
Role: STUDY_CHAIR
Washington University School of Medicine
Ariana Smith, MD
Role: STUDY_CHAIR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of California, San Diego
San Diego, California, United States
Yale University
New Haven, Connecticut, United States
Emory University
Atlanta, Georgia, United States
Loyola University Chicago
Chicago, Illinois, United States
Northwestern University
Chicago, Illinois, United States
University of Michigan
Ann Arbor, Michigan, United States
Washington University School of Medicine
St Louis, Missouri, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00012315
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.